Trending

Epizyme

Epizyme scores important follicular lymphoma approval with Tazverik

Epizyme scores important follicular lymphoma approval with Tazverik

Epizyme has scored an important FDA win after the regulator approved its Tazverik (tazemetostat) in follicular lymphoma. Tazverik is already approved in

X

Epizyme scores important follicular lymphoma approval with Tazverik

https://pharmaphorum.com/news/epizyme-unlocks-more-sales-with-tazverik-follicular-lymphoma-approval/

FDA approves Epizyme’s Tazverik in sarcoma

FDA approves Epizyme’s Tazverik in sarcoma

The US regulator has approved Epizyme’s Tazverik (tazemetostat) for advanced sarcoma, providing a new option for a disease

X

FDA approves Epizyme’s Tazverik in sarcoma

https://pharmaphorum.com/news/fda-approves-epizymes-tazverik-in-sarcoma/

4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED

4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED

Drug Discovery Conference

X

4 KEY QUESTIONS IN NEW EXPERIMENTAL TECHNOLOGIES ANSWERED

https://pharmaphorum.com/partner-content/4-key-questions-in-new-experimental-technologies-answered/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com